Similarly, in membranous nephropathy, Moshen granule treatment alleviated kidney injury by activating the aryl hydrocarbon receptor (AhR), which upregulated Nrf2 and subsequently enhanced MnSOD expression, reducing oxidative stress and inflammation [58]. This evidence concerns the gene AHR and membranous glomerulonephritis.